Trulicity (dulaglutide) - Eli Lilly
Zepbound (tirzepatide) - Eli Lilly
Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes (clinicaltrials.gov) - Sep 23, 2026 - P3 | N=150 | Completed | Sponsor: Zagazig University 
New P3 trial • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity
http://clinicaltrials.gov/ct2/show/NCT07834398
 
Sep 23, 2026
 
Prev Next